Form 4: Centessa Pharmaceuticals' General Counsel, Iqbal Hussain, Reports Changes in Beneficial Ownership

Iqbal Hussain, General Counsel of Centessa Pharmaceuticals, reports the disposal of 7,520 ordinary shares to cover tax obligations and discloses beneficial ownership of 197,490 ordinary shares directly and 5,500 indirectly through a spouse.

Summary

• On September 30, 2024, Iqbal Hussain, the General Counsel of Centessa Pharmaceuticals plc, reported a transaction involving the company's ordinary shares.
• Hussain disposed of 7,520 ordinary shares at a price of $15.79 per share to cover tax withholding obligations related to the vesting of restricted share units.
• Following the transaction, Hussain directly owns 197,490 ordinary shares and indirectly owns 5,500 ordinary shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It is standard practice for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates